<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00998465</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-99</org_study_id>
    <nct_id>NCT00998465</nct_id>
  </id_info>
  <brief_title>Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity</brief_title>
  <official_title>Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity - Effect of Weight Loss Following Laparoscopic Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zealand University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of high vs. low sodium intake on blood&#xD;
      pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact&#xD;
      of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in&#xD;
      morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms&#xD;
      involved in the amelioration of blood pressure during long-term weight loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overweight and obesity are rapidly increasing in Western countries and are associated with&#xD;
      increased mortality and morbidity. The increased morbidity is assumed to be mediated mainly&#xD;
      by insulin resistance, diabetes, hypertension and lipid disturbances, but obesity also&#xD;
      represents an independent risk factor for cardiovascular disease.&#xD;
&#xD;
      Obesity is associated with an increased risk of hypertension but the pathophysiological basis&#xD;
      is not fully established. Several studies have indicated that blood pressure of obese&#xD;
      patients could be more dependent on dietary sodium intake than the blood pressure of&#xD;
      non-obese patients(as it is the case for patients with essential hypertension)and that this&#xD;
      sodium sensitivity of blood pressure is lost after weight loss.&#xD;
&#xD;
      To date, bariatric surgery is the only therapy resulting in substantial and durable long-term&#xD;
      weight loss, and the beneficial effects on obesity-related co-morbidities have been well&#xD;
      documented. Laparoscopic gastric bypass results in a remarkable improvement of glucose&#xD;
      homeostasis and a resolution of diabetes, that typically occurs too fast to be accounted for&#xD;
      by weight loss alone. Furthermore, an immediate reduction of blood pressure following&#xD;
      laparoscopic gastric bypass has been demonstrated in morbidly obese patients with&#xD;
      hypertension as early as one week after the operation. As with the rapid reduction of&#xD;
      diabetes, the antihypertensive effect of the procedure might be a consequence of the&#xD;
      rearrangement of the gastrointestinal anatomy.&#xD;
&#xD;
      With this study, we want to evaluate the effect of high vs. low sodium intake on blood&#xD;
      pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact&#xD;
      of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in&#xD;
      morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms&#xD;
      involved in the amelioration of blood pressure during long-term weight loss. Therefore,&#xD;
      patients are examined before, 4-6 weeks after and one year after laparoscopic gastric bypass.&#xD;
&#xD;
      Before and one year after the operation, the patients are examined two times; in a five days&#xD;
      period of a low dietary sodium consumption and in a five days period of a high sodium&#xD;
      consumption respectively. Four-six weeks following the operation, the patients are examined&#xD;
      once on their usual diet.&#xD;
&#xD;
      The protocol comprise three sub studies:&#xD;
&#xD;
        1. The effect of high vs low sodium intake on blood pressure and hemodynamics in the morbid&#xD;
           obese patient - preoperative study.&#xD;
&#xD;
        2. Effect of gastric bypass surgery on blood pressure, hemodynamics and salt-sensitivity -&#xD;
           1 year follow-up.&#xD;
&#xD;
        3. Effect of gastric bypass surgery on echocardiographic parameters - 1 year follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sodium induced change in 24-hour blood pressure before and one year after laparoscopic gastric bypass.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiography: Dimensions, systolic and diastolic function before and one year after laparoscopic gastric bypass</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-invasive hemodynamic measurements (inert gas rebreathing) before and one year after laparoscopic gastric bypass</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition: Dexa-scan, plasma volume and extracellular volume before and one year after laparoscopic gastric bypass</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood samples: MR-proANP, p-glucose, p-insulin</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">36</enrollment>
  <condition>Obesity</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <description>Obese patients with hypertension and a body mass index 40-50 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Control subjects without hypertension and body mass index &lt; 30 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese, normotension</arm_group_label>
    <description>Obese patients without hypertension and a BMI between 40-50 kg/m2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>24-hour blood pressure</intervention_name>
    <description>Blood pressure is measured every 15 minutes in the daytime and every 30 minutes at night</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Standard 2-D and m-mode echocardiography with determination of dimensions, systolic, and diastolic function.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inert gas rebreathing</intervention_name>
    <description>Cardiac output, stroke volume and total peripheral resistance are tested at rest and during exercise (bicycle ergometer) using non-invasive equipment (inert gas rebreathing - Innocor)</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Dexa-scan</intervention_name>
    <description>Fat mass and fat free mass is determined with a whole body Dexa scan, and bone mineral density is tested with Dexa-scans of the lumbar spine and proximal femur.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Plasma volume</intervention_name>
    <description>The test is performed using 5 MBq technetium-labeled albumine (99mTc-albumine - Vasculosis) with several postinjection samples for accurate zero-time extrapolation.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Glomerular filtration rate (GFR)</intervention_name>
    <description>GFR and ECV are determined following injection of 3,7 MBq 51Cr-EDTA and postinjection samples three-four hours after injection.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples</intervention_name>
    <description>p-glucose, p-insulin, NT-proBNP, hemoglobin, potassium, sodium, creatinine, albumine</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Urine analyses</intervention_name>
    <description>24-hour urine collections with determination of u-sodium, u-potassium and u-creatinine.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Diets with low and high sodium content</intervention_name>
    <description>Participants are subjected to 5 days of low (90 mmol/day) and high (250 mmol/day) sodium intake in a randomized order before and 1 year after laparoscopic gastric bypass surgery.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Obese, hypertension</arm_group_label>
    <arm_group_label>Obese, normotension</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples: p-glucose, p-insulin, MR-proANP, hemoglobine, sodium, potassium, creatinine,&#xD;
      albumine.&#xD;
&#xD;
      Urine collections: u-sodium, u-potassium, u-creatinine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The cases are recruited from the Bariatric Clinics at Glostrup Hospital, Koege Hospital and&#xD;
        The Private Hospital Hamlet.&#xD;
&#xD;
        Controls are recruited through public advertisement&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (cases):&#xD;
&#xD;
          -  Caucasians fulfilling the criteria for laparoscopic gastric bypass.&#xD;
&#xD;
          -  12 participants with hypertension, defined as blood pressure &gt; 140/90 and/or use of&#xD;
             antihypertensive medication and 12 participants without hypertension.&#xD;
&#xD;
          -  Body mass index 40-50 kg/m2&#xD;
&#xD;
        Inclusion Criteria (controls):&#xD;
&#xD;
          -  Caucasian.&#xD;
&#xD;
          -  No hypertension or use of antihypertensive medication.&#xD;
&#xD;
          -  Body mass index &lt; 30 kg/m2&#xD;
&#xD;
        Exclusion Criteria (all):&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Medical treatment with sibutramine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter K Bonfils, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morten Damgaard, MD, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hvidovre Hospital, Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mustafa Taskiran, MD, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Viggo B Kristiansen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Glostrup Hospital, Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Knud H Stokholm, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niels Gadsboll, MD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Koege, Department of Clinical Physiology and Nuclear Medicine</name>
      <address>
        <city>Koege</city>
        <zip>DK-4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <study_first_submitted>October 19, 2009</study_first_submitted>
  <study_first_submitted_qc>October 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2009</study_first_posted>
  <last_update_submitted>March 19, 2013</last_update_submitted>
  <last_update_submitted_qc>March 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2013</last_update_posted>
  <responsible_party>
    <name_title>Peter Kramshoj Bonfils, MD</name_title>
    <organization>University Hospital Koege</organization>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Salt sensitivity</keyword>
  <keyword>Laparoscopic gastric bypass</keyword>
  <keyword>Bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

